Citation Impact
Citing Papers
Actin retrograde flow actively aligns and orients ligand-engaged integrins in focal adhesions
2017 StandoutNobel
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Breast cancer stem cells: implications for therapy of breast cancer
2008
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
2009
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Gastric cancer
2016 Standout
Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
2008
Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
2012
Triple-Negative Breast Cancer
2010 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Molecular imaging in drug development
2008 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Breast cancer
2016 Standout
68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging
2009
Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases
2006
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
The dual role of thymidine phosphorylase in cancer development and chemotherapy
2009
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Using imaging biomarkers to accelerate drug development and clinical trials
2005
The biology and function of fibroblasts in cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Esophageal Cancer
2003 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Assessing responses to cancer therapy using molecular imaging
2006
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
2009
Regulation of cancer cell metabolism
2011 Standout
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
New approaches for imaging tumour responses to treatment
2008
Emerging Biological Principles of Metastasis
2017 Standout
[68Ga]NS3-RGD and [68Ga] Oxo-DO3A-RGD for imaging αvβ3 integrin expression: synthesis, evaluation, and comparison
2012
Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues
2001
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Molecular imaging by mass spectrometry — looking beyond classical histology
2010
Microenvironmental regulation of metastasis
2008 Standout
Angiogenesis inhibitors in the management of breast cancer
2009
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
2015
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
2013
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Tumour evolution inferred by single-cell sequencing
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Dual Integrin and Gastrin-Releasing Peptide Receptor Targeted Tumor Imaging Using 18F-labeled PEGylated RGD-Bombesin Heterodimer 18F-FB-PEG3-Glu-RGD-BBN
2008
Positron Emission Tomography Scanning: Current and Future Applications
2002
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Mass spectrometry-based proteomics
2003 StandoutNature
Cytokine Storm
2020 Standout
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
Chimeric Antigen Receptor Therapy
2018 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Cancer Genome Landscapes
2013 StandoutScience
Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization
2004 StandoutScience
18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
2009
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
2003
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Chemical Glycoproteomics
2016 StandoutNobel
Works of Jörg Nährig being referenced
Differential expression of c‐Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue
2007
Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
2011
Quantitative protein analysis from formalin‐fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis
2006
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
2007
Patterns of αvβ3 Expression in Primary and Metastatic Human Breast Cancer as Shown by 18F-Galacto-RGD PET
2008
Quantification of CK20 gene and protein expression in colorectal cancer by RT‐PCR and immunohistochemistry reveals inter‐ and intratumour heterogeneity
2002
Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors—correlation to tumor histopathology and clinical follow-up
2005
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study
2006
Chromosomal Imbalances are Associated with Metastasis‐Free Survival in Breast Cancer Patients
2002
Protocol for ultrarapid immunostaining of frozen sections.
1999
Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
2000
FGFR4 Arg388 Allele Is Associated With Resistance to Adjuvant Therapy in Primary Breast Cancer
2006